Isabel Cristina Ferreira Tavares

Isabel Cristina Ferreira Tavares

Auto-generated profile, based on publicly available information

Isabel Cristina Ferreira Tavares

Evandro Chagas Infectious Diseases National Institute Oswaldo Cruz Foundation Rio de Janeiro Brazil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2025 in Journal of Ultrasound in Medicine
Verified
Journal Article
Open access
CFClévio Cezar da Fonseca
Clévio Cezar da Fonseca
HPHugo Perazzo
Hugo Perazzo
SCSandra W. Cardoso
Sandra W. Cardoso
ITIsabel Cristina Ferreira Tavares
Isabel Cristina Ferreira Tavares
MRMaria Pia Diniz Ribeiro
Maria Pia Diniz Ribeiro
PBPedro Emmanuel Alvarenga Americano do Brasil
Pedro Emmanuel Alvarenga Americano do Brasil
Objectives: The risk of major venous thromboembolism (VTE) among patients with COVID‐19 is high but varies with disease severity. Estimate the incidence of lower extremity deep venous thrombosis (DVT) in critically ill hospitalized patients with COVID‐19, validate the Wells score for DVT diagnosis, and determine patients' prognosis. Methods: This was an observational follow‐up study in the context of the diagnosis and prognosis of DVT. All patients were hospitalized in the intensive care unit (ICU) of the Evandro Chagas National Institute of Infectious Diseases. Participants with COVID‐19 pneumonia were included. Lower‐limb Doppler to assess DVT was performed at admission and follow‐up. Prognosis outcomes were death, length of stay, need for mechanical ventilation, vasopressor use, and hemodialysis. Wells' score sensitivity and specificity were estimated at admission. Survival curves were estimated for patients with DVT and adjusted for the SAPS 3 score. Results: Between June 2020 and January 2021, 186 patients were included. The DVT incidence was 0.097. A Wells score of 2 or higher had a sensitivity and specificity of 1.00 and 0.94, respectively. Mortality and mechanical ventilation support were higher in participants with DVT. For these outcomes, after SAPS 3 adjustment, participants with DVT had twice the hazard of those without DVT. A web calculator ( https://pedrobrasil.shinyapps.io/INDWELL/ ) is available for predictions. Conclusions: One can use the Wells score to accurately diagnose DVT in critically ill patients with COVID‐19. DVT increases the severity of COVID‐19, which highlights the importance of its early diagnosis, treatment, and prophylaxis in the ICU setting.

2 May 2025 in medRxiv
Verified
Preprint
Open access
PDF file
CFClévio Cezar da Fonseca
Clévio Cezar da Fonseca
HPHugo Perazzo
Hugo Perazzo
SCSandra W. Cardoso
Sandra W. Cardoso
ITIsabel Cristina Ferreira Tavares
Isabel Cristina Ferreira Tavares
MRMaria Pia Diniz Ribeiro
Maria Pia Diniz Ribeiro
PBPedro Emmanuel Alvarenga Americano do Brasil
Pedro Emmanuel Alvarenga Americano do Brasil
BACKGROUND: The risk of major venous thromboembolism (VTE) among patients with COVID-19 is high but varies with disease severity. OBJECTIVE: Estimate the incidence of lower extremity deep venous thrombosis (DVT) in critically ill hospitalized patients with COVID-19, validate the Wells score for DVT diagnosis, and determine patient’s prognosis. DESIGN AND SETTING: This was an observational follow-up study in the context of diagnosis and prognosis of DVT. All patients hospitalized in the intensive care unit (ICU) of the Evandro Chagas National Institute of Infectious Diseases. METHODS: Participants with COVID-19 pneumonia were included. Lower-limb Doppler to assess DVT was performed at admission and follow-up. Prognosis outcomes were death, length of stay, need for mechanical ventilation, vasopressor use, and hemodialysis. Wells’ score sensitivity and specificity were estimated at admission. Survival curves were estimated for patients with DVT and adjusted for the SAPS3 score. RESULTS: Between June 2020 and January 2021, 186 patients were included. The DVT incidence was 0.097. A Wells score of two or higher had a sensitivity and specificity of 1.00 and 0.94 respectively. Mortality and mechanical ventilation support were higher in participants with DVT. For these outcomes, after SAPS 3 adjustment, participants with DVT had twice the hazard of those without DVT. A web calculator ( https://pedrobrasil.shinyapps.io/INDWELL/ ) is available for predictions. CONCLUSIONS: One can use the Wells score to accurately diagnose DVT in critically ill patients with COVID-19. DVT increases severity of COVID-19, which highlights the importance of its early diagnosis, treatment, and prophylaxis at the ICU setting.